Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador: A Decade in Remission from Blood Cancer

Leukaemia Foundation 2 mins read
Hon. Anna Bligh AC announced as Leukaemia Foundation Ambassador.

The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC.

 

As the former Premier of Queensland and current CEO of the Australian Banking Association, Ms Bligh is a survivor of the blood cancer Non-Hodgkin lymphoma, after being diagnosed in 2013.

 

Ms Bligh will immediately step into her role as National Ambassador, bringing with her a wealth of experience to passionately advocate for fellow Australians impacted by blood cancer. 

 

Chris Tanti, CEO of the Leukaemia Foundation, said of Ms Bligh's appointment, "Anna Bligh embodies the essence of resilience and compassion.”

 

“Her journey is a testament to leadership and empathy and underscores her unwavering dedication to service. We are both proud and excited to welcome Anna into the Leukaemia Foundation family."

 

Ms Bligh's appointment arrives as she marks a decade in remission from blood cancer. Her personal experience with the disease stands as an inspiration for countless individuals and families currently impacted around Australia.

 

On accepting her new role, Ms Bligh said, "To the 140,000 Australians and their families currently living with blood cancer, I want you to know that you are not alone.”

 

“I am humbled to join the Leukaemia Foundation as a National Ambassador and hope I can use my personal experience to support others impacted by this disease as well raise further awareness of blood cancer within the community.

 

“Together we will strive to achieve our collective goal of zero lives lost to blood cancer by 2035."

 

Ms Bligh's illustrious career spans leadership roles in both the public and private sectors. As Premier of Queensland from 2007 to 2012, she enacted visionary economic reforms and guided the state through turbulent times, including natural disasters.

 

Her tenure as CEO of the Australian Banking Association saw her at the forefront of pivotal reforms within the banking sector, earning acclaim for her steadfast commitment to rebuilding trust and nurturing integrity.

 

Now, as a Leukaemia Foundation Ambassador, Ms Bligh will tirelessly champion the organisation’s mission, driving awareness and support for expert care, groundbreaking blood cancer research, and impactful campaigns to propel progress for Australians facing the challenges of blood cancer.

 

For more information on Anna Bligh’s appointment as a Leukaemia Foundation Ambassador, visit leukaemia.org.au/about-us/ambassadors/ or call 1800 620 420.

 

-END-

 

 

INTERVIEW LEUKAEMIA FOUNDATION CEO:

Chris Tanti, CEO, is available to discuss the new National Ambassador appointment of Hon. Anna Bligh AC in detail via phone, Zoom, Teams or in person (Melbourne).


About us:

About the Leukaemia Foundation: The Leukaemia Foundation stands with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at leukaemia.org.au.


Contact details:

Contact our media team - media@leukaemia.org.au 

Media

More from this category

  • Medical Health Aged Care
  • 26/07/2024
  • 22:10
OmniGuide Holdings

OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology

BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion of a groundbreaking patient study for its innovative iSTONE™ software, a laser-guided system designed for real-time automatic target identification in endoscopic stone lithotripsy. This advancement marks a significant milestone in the treatment of urolithiasis, promising a new era of precision and safety in kidney stone management.In August 2022, the German Federal Ministry of Education and Research recognized the potential of this pioneering technology, awarding LISA Laser Products GmbH, a subsidiary of OmniGuide Holdings based in Germany, a prestigious grant (Grant…

  • CharitiesAidWelfare, Entertainment
  • 26/07/2024
  • 13:37
AAGilesberg Production | Get Free Movie

Join Us on International Anti-Human Trafficking Day for the “Get Free” Screening and Q&A on July 30

Penrith, July 30 at 7:15pm – This International Anti-Human Trafficking Day, join us for a poignant evening of cinema and advocacy at the screening…

  • Contains:
  • Disability, Medical Health Aged Care
  • 26/07/2024
  • 12:57
Mr River Night

Fear as Services Australia Staff Face the Backlash from NDIS Communication Blackouts with its 600 000 + Participants

Available for Comment Radio – Live, Pre-recorded and Talkback, TV, Print Mr River Night Leading National Disability Sector Advocate Co-founder at Developing Australian Communities…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.